Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lazzaroni

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Lupus|March 6, 2016
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosusM Taraborelli, L Leuenberger, M G Lazzaroni, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrumClodoveo Ferri, Dilia Giuggioli, Serena Guiducci, et al.
The Journal of Rheumatology|January 15, 2025
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR RegistryFabio Cacciapaglia, Rossella De Angelis, Clodoveo Ferri, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Lupus|March 6, 2016
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosusM Taraborelli, L Leuenberger, M G Lazzaroni, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrumClodoveo Ferri, Dilia Giuggioli, Serena Guiducci, et al.
The Journal of Rheumatology|January 15, 2025
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR RegistryFabio Cacciapaglia, Rossella De Angelis, Clodoveo Ferri, et al.
Pageof 2